CMEI MedicarePhysicianJune2025 F

New Study: Medicare’s Price Controls Are Fueling America’s Growing Doctor Shortage

The Pacific Research Institute’s Center for Medical Economics and Innovation today released a new issue brief warning that continued federal underpayment of doctors is fueling a looming healthcare crisis by accelerating the nation’s physician shortage and undermining access to care. Written by PRI senior fellow in business and economics and CMEI director Dr. Wayne Winegarden, the brief (titled “It’s Time for Medicare to Stop Shortchanging Physicians”) finds that Medicare reimbursement rates are well below market ...
worlds medicine chest

Read the new book from Sally Pipes “The World’s Medicine Chest”

Just released from PRI – read The World’s Medicine Chest, the latest book from PRI President, CEO and Thomas W. Smith Fellow in Health Care Policy. <The World’s Medicine Chest explores how America became the world’s leader in biopharmaceutical innovation through market capitalism. Click here to register to watch a special live webinar with Pipes on Wednesday, February 26 at 11 AM Pacific time, discussing her new book in conversation with PRI’s Dr. Wayne Winegarden. In ...
HoldingDrugCapsule mikhail nilov 8851255 copy

Learn How Drug Price Controls Hurt Patients

Big Pharma Is Not Gouging Americans nor Driving Up Healthcare Costs

Whether it is Sanders vilifying pharmaceutical companies or Trump’s emphasis on imposing price controls, they both allege that drug spending is a primary driver of the nation’s rising healthcare costs. Even a cursory look at the data demonstrates their focus is misplaced. Let’s start with the national health expenditure data that shows the U.S. currently spends around $5 trillion annually, or $15,000 per person, on healthcare. This is a gargantuan amount. Prescription drug spending accounts ...

Trending Topics

Studies

CMEI PromotingHealthCare Oct25 FCover
CMEI PACE analysis FinalCover
N CMEI DrugIndustry SP F Page Cover
CMEI MedicarePhysicianJune2025 F
CMEI MFA March2025 F Cover
FailureMarketClaims Gilead F cover
FinalBiosimilarFeaturedImage
FinalBiosimilarFeaturedImage
FinalBiosimilarFeaturedImage
FinalBiosimilarFeaturedImage
Medicare July2024 F cover
Biosimilars June2024 rFCover
Scroll to Top